Thursday, April 19, 2012
Moffitt Cancer Center Researchers Find Cancer Therapies Affect Cognitive Functioning among Breast Cancer Survivors

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and University of Kentucky have found that breast cancer survivors who have had chemotherapy, radiation or both do not perform as well on some cognitive tests as women who have not had cancer. They published their study in the April 1 issue of CANCER. ..

Read More
Monday, April 02, 2012
Moffitt Cancer Center Researchers Validate New Staging Classifications for Neuroendocrine Pancreatic Tumor Surgery Response

Researchers at Moffitt Cancer Center have carried out a study to validate the utility of new tumor classification systems for staging and predicting relapse-free survival for patients with neuroendocrine tumors (NETs) and who may be candidates for surgery. The results of their study were published in a recent issue of the Annals of Surgery. ..

Read More
Friday, March 30, 2012
Scripps Florida Scientists Win $2 Million to Study New Pathway Important in the Development and Maintenance of Lymphoma

The National Institutes of Health has awarded The Scripps Research Institute $2 million to study the role of a pathway in the development and maintenance of B-cell lymphoma, a type of cancer that begins in immune system and turns normal disease fighting cells into cancers. The disease affects immune cells known as lymphocytes, which are part of our white blood cells. ..

Read More
Friday, March 23, 2012
Moffitt Cancer Center Researchers Link Stigma To Depression Among Lung Cancer Patients

Studying the role of social stigma in depression for lung cancer patients, researchers at Moffitt Cancer Center in Tampa, Fla., have found that depression can be heightened by a lung cancer patient's sense of social rejection, internalized shame and social isolation. These factors may contribute to depression at rates higher than experienced by patients with other kinds of cancer.  ..

Read More
Saturday, February 04, 2012
UF: Targeting tumors may help stop spread of breast, other cancers

Cancer that has spread from the site of an original tumor to other places in the body is often viewed as a death sentence. But if there are just a few of those secondary tumors, called metastases, some patients have a good chance of survival if treated with a type of radiation that precisely targets small tumors, researchers at the University of Florida and the University of Rochester report online and in an upcoming print edition of the International Journal of Radiation Oncology, Biology, Physics. ..

Read More
Friday, January 06, 2012
Moffitt Cancer Center Researchers Find Malignancy-Risk Gene Signature For Early-Stage Non-Small Cell Lung Cancer

A malignancy-risk gene signature developed for breast cancer has been found to have predictive and prognostic value for patients with early stage non-small cell lung cancer. The advancement was made by researchers at Moffitt Cancer Center in Tampa, Fla., who published their study results in a recent issue of the Journal of the National Cancer Institute. ..

Read More
Thursday, January 05, 2012
Fibroblasts Contribute To Melanoma Tumor Growth, Say Moffitt Cancer Center Researchers

Fibroblasts, cells that play a role in the structural framework of tissues, play an apparent role in melanoma tumor growth. Fibroblasts also contribute to melanoma drug resistance and may also facilitate the "flare" response when a tumor's metabolism is enhanced following a patient being removed from a targeted therapy, said researchers at Moffitt Cancer Center in Tampa, Fla.  ..

Read More
Wednesday, December 14, 2011
Moffitt Cancer Center Researchers Find Potential Target For Treating Metastatic Cancer

Finding ways to counteract or disrupt the invasive nature of cancer cells, called "metastasis," has been a long-term goal of cancer researchers. Now, researchers at Moffitt Cancer Center in Tampa, Fla., have identified an interactive pathway that regulates metastases in some cancers that may be vulnerable to chemical targeting in order to prevent cancer cell proliferation and tumor growth. ..

Read More
Thursday, November 03, 2011
Moffitt Cancer Center Researchers Help In Search For New Ways To Image And Therapeutically Target Melanoma

Because the incidence of malignant melanoma is rising faster than any other cancer in the U.S., researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Tampa-based Intezyne Technologies, Inc., Western Carolina University and the University of Arizona are working overtime to develop new technologies to aid in both malignant melanoma diagnosis and therapy. A tool of great promise comes from the world of nanomedicine - where tiny drug delivery systems are measured in the billionths of meters and are being designed to deliver targeted therapies.  ..

Read More
Friday, October 28, 2011
Moffitt Cancer Center Researchers Find More Clues To Causes Of Breast Cancer

Publishing in the current issue of The Journal of Biological Chemistry (Vol. 286, No 43), researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of "Akt" activation and suggest a component of that activation mechanism - inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) - could be targeted as a therapeutic intervention for treating cancer. ..

Read More